Landi, D., Centonze, D., Marfia, G.a., Capra, R., Scarpazza, C. (2018). Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue.". JOURNAL OF CLINICAL APHERESIS, 33(3), 450-451 [10.1002/jca.21616].
Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue."
Landi D.;Centonze D.;Marfia G. A.;
2018-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Landi, 2018.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
83.15 kB
Formato
Adobe PDF
|
83.15 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
